Yazar "Aksoy, Sinem" için listeleme

Toplam kayıt 1, listelenen: 1-1

Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort

Kaya, Eda; Aksoy, Sinem; Oruc, Nazlıcan; Taşdemir, Çağla; Cengiz, Beyza İrem; Keklikkıran, Çağlayan; Yılmaz, Yusuf (Kare Publishing, 2025)

Background and Aim: Resmetirom received conditional Food and Drug Administration (FDA) approval in 2024 for metabolic dysfunction-associated steatotic liver disease (MASLD) based on its promising liver-targeted therapy. ...